By Sarah Owermohle and Susannah Luthi

Drugmakers pitched a counteroffer to the White House aimed at stalling Trump’s plan to link Medicare’s spending on some expensive drugs to much lower prices.

Drugmakers pitched a counteroffer to the White House aimed at stalling Trump’s plan to link Medicare’s spending on some expensive drugs to much lower prices.

Drugmakers pitched a counteroffer to the White House aimed at stalling Trump’s plan to link Medicare’s spending on some expensive drugs to much lower prices.

Drugmakers pitched a counteroffer to the White House aimed at stalling Trump’s plan to link Medicare’s spending on some expensive drugs to much lower prices.

Drugmakers pitched a counteroffer to the White House aimed at stalling Trump’s plan to link Medicare’s spending on some expensive drugs to much lower prices.